A potential role for caveolin-1 in VEGF-induced fibronectin upregulation in mesangial cells: involvement of VEGFR2 and Src (Q28567391)

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

VEGF/PLGF induces leukemia cell migration via P38/ERK1/2 kinase pathway, resulting in Rho GTPases activation and caveolae formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Vascular endothelial growth factor and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

VEGF-receptor signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Distinct endocytic pathways regulate TGF-β receptor signalling and turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Role of vascular endothelial growth factor in kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Vascular endothelial growth factor induces endothelial fenestrations in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

The vascular endothelial growth factor family of polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Reactive oxygen species and matrix remodeling in diabetic kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Update of extracellular matrix, its receptors, and cell adhesion molecules in mammalian nephrogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Diabetic nephropathy: mechanisms of renal disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Epidermal Growth Factor-stimulated Tyrosine Phosphorylation of Caveolin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Nitric Oxide Inhibits Stretch-Induced MAPK Activation in Mesangial Cells Through RhoA Inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Compartmentalizing VEGF-induced ERK2/1 signaling in placental artery endothelial cell caveolae: a paradoxical role of caveolin-1 in placental angiogenesis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Increased expression of vascular endothelial growth factor in kidney leads to progressive impairment of glomerular functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Multiple functions of caveolin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Extracellular matrix metabolism in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Regulated migration of epidermal growth factor receptor from caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Vascular endothelial growth factor (VEGF) in the pathogenesis of diabetic nephropathy of type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

A new role for caveolae as metabolic platforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

The biology of caveolae: achievements and perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

RhoA activation in mesangial cells by mechanical strain depends on caveolae and caveolin-1 interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

TGFbeta-induced RhoA activation and fibronectin production in mesangial cells require caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Caveolin-1: an ambiguous partner in cell signalling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Caveolae: from cell biology to animal physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Selective stimulation of VEGFR2 accelerates progressive renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Caveolins in cholesterol trafficking and signal transduction: implications for human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

The role of vascular endothelial growth factor (VEGF) in renal pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Caveolae and caveolin in transmembrane signaling: Implications for human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Gp60 Activation Mediates Albumin Transcytosis in Endothelial Cells by Tyrosine Kinase-dependent Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Regulation of vascular endothelial growth factor expression by advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Transforming growth factor-beta1 stimulates vascular endothelial growth factor 164 via mitogen-activated protein kinase kinase 3-p38alpha and p38delta mitogen-activated protein kinase-dependent pathway in murine mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Rosiglitazone prevents high glucose-induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Caveolin is an activator of insulin receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012

Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00294.2012